Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0FL7O
|
|||
Former ID |
DNC012639
|
|||
Drug Name |
4-Biphenyl-4-yl-2-(1-pentyl-hexyl)-1H-imidazole
|
|||
Synonyms |
CHEMBL332257; SCHEMBL4817122
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C26H34N2
|
|||
Canonical SMILES |
CCCCCC(CCCCC)C1=NC=C(N1)C2=CC=C(C=C2)C3=CC=CC=C3
|
|||
InChI |
1S/C26H34N2/c1-3-5-8-14-24(15-9-6-4-2)26-27-20-25(28-26)23-18-16-22(17-19-23)21-12-10-7-11-13-21/h7,10-13,16-20,24H,3-6,8-9,14-15H2,1-2H3,(H,27,28)
|
|||
InChIKey |
FAJKZAIMTCYING-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sodium channel unspecific (NaC) | Target Info | Inhibitor | [1] |
Voltage-gated sodium channel alpha Nav1.3 (SCN3A) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Dopaminergic synapse | |||
Reactome | Interaction between L1 and Ankyrins |
References | Top | |||
---|---|---|---|---|
REF 1 | 2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators. Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.